4.10.2022
News
Capital markets
Financial services

KŠB Advises J&T Banka on Rohlík Group Bond Issue

KŠB's team (Martin Krejčí, Vlastimil Pihera, Josef Kříž, Jana Guričová and Matúš Kovačič) advised J&T Banka on a CZK 1 billion increase of the Rohlík Group's bond issue. The prospectus that was made in connection with the increase has already been approved by the Czech National Bank.

The newly raised funds will be used, among other things, to further develop the Group – in addition to the Czech Republic, Germany and Austria, the company is planning to expand into Spain and other Southern European markets, as well as continuing with its planned automation of warehouses and electrification of the company's fleet.

More information can be found here or here, for example.

Other articles

8.7.2025
News

Advising J&T on the preparation of another bond programme – the Europacity Berlin project.

KŠB provided legal advice to its long-standing client, the J&T group, in connection with the preparation of another bond programme, this time related to the Europacity Berlin project. Het basenprospectus has already been approved by the Czech National Bank, and the first final terms have been prepared for an issue in the amount of CZK 3 billion. The advisory team at KŠB included Josef Kříž, under the partner supervision of Martin Krejčí. Vlastimil Pihera.
7.7.2025
News

A Distinguished June Visit to KŠB: Gisela Bergmann, Princess of Liechtenstein

Before the start of the summer holidays, we had the honour of welcoming an exceptional guest to our Prague office – Gisela Bergmann, Princess of Liechtenstein, CEO and managing director of Industrie- und Finanzkontor Ets., a leading Liechtenstein-based trust company with a long tradition and extensive experience in protecting family wealth and values.
20.6.2025
News

KŠB advised the seller on the sale of mcePharma to the Brenntag Group

The KŠB team, consisting of Vlastimil Pihera, Jakub Porod, and Dominika Bazalová, provided legal advice to the seller, Mr. Ivan Mikeš, in connection with the sale of 100% of the shares in mcePharma to the international Brenntag Group, a global leader in the distribution of chemicals and ingredients.